Switch theme
Sign up to access all valuation multiples
Gr. Sarantis SA is a consumer products manufacturer that offers cosmetics, including aftershave lotions and deodorants with brands such as Adidas and C-THRU; household products including food packaging, cleaning, and shoe care products of such brands as Sanitas and Camel; and health & care products & para pharmaceutical products including vitamins and food supplements, pregnancy and ovulation tests, and sun care products, and luxury cosmetics, including fragrance, treatment, and makeup products under its brands and various other brands. It operates in segments: Beauty / Skin Care / Sun Care, Personal Care, Home Care Solutions, Private Label, Strategic Partnerships and Other Sales. The geographical segments are Greece, Ukraine, Poland, Romania, Czech, Hungary, Slovakia, and others.
1964
3.1K+
LTM Revenue $693M
LTM EBITDA $96.2M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sarantis Group has a last 12-month revenue of $693M and a last 12-month EBITDA of $96.2M.
In the most recent fiscal year, Sarantis Group achieved revenue of $682M and an EBITDA of $93.5M.
Sarantis Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sarantis Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $548M | $682M | XXX | XXX | XXX |
| Gross Profit | $173M | $207M | XXX | XXX | XXX |
| Gross Margin | 31% | 30% | XXX | XXX | XXX |
| EBITDA | $76.1M | $93.5M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 14% | XXX | XXX | XXX |
| Net Profit | $51.6M | $44.7M | XXX | XXX | XXX |
| Net Margin | 9% | 7% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 30, 2025, Sarantis Group's stock price is EUR 13 (or $15).
Sarantis Group has current market cap of EUR 847M (or $963M), and EV of EUR 880M (or $1.0B).
See Sarantis Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $963M | XXX | XXX | XXX | XXX | $1.16 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of April 30, 2025, Sarantis Group has market cap of $963M and EV of $1.0B.
Sarantis Group's trades at 1.4x LTM EV/Revenue multiple, and 10.4x LTM EBITDA.
Analysts estimate Sarantis Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Sarantis Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.0B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | XXX | XXX |
| P/E | 18.4x | XXX | XXX | XXX |
| P/E/Growth | 1.2x | XXX | XXX | XXX |
| EV/FCF | 19.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSarantis Group's NTM/LTM revenue growth is 5%
Sarantis Group's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Sarantis Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Sarantis Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Sarantis Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 23% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 19% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 27% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| PharmaSGP | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sarantis Group acquired XXX companies to date.
Last acquisition by Sarantis Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Sarantis Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Sarantis Group founded? | Sarantis Group was founded in 1964. |
| Where is Sarantis Group headquartered? | Sarantis Group is headquartered in Greece. |
| How many employees does Sarantis Group have? | As of today, Sarantis Group has 3.1K+ employees. |
| Who is the CEO of Sarantis Group? | Sarantis Group's CEO is Mr. Ioannis K. Bouras. |
| Is Sarantis Group publicy listed? | Yes, Sarantis Group is a public company listed on ATH. |
| What is the stock symbol of Sarantis Group? | Sarantis Group trades under SAR ticker. |
| When did Sarantis Group go public? | Sarantis Group went public in 1994. |
| Who are competitors of Sarantis Group? | Similar companies to Sarantis Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Sarantis Group? | Sarantis Group's current market cap is $963M |
| What is the current revenue of Sarantis Group? | Sarantis Group's last 12-month revenue is $693M. |
| What is the current EBITDA of Sarantis Group? | Sarantis Group's last 12-month EBITDA is $96.2M. |
| What is the current EV/Revenue multiple of Sarantis Group? | Current revenue multiple of Sarantis Group is 1.4x. |
| What is the current EV/EBITDA multiple of Sarantis Group? | Current EBITDA multiple of Sarantis Group is 10.4x. |
| What is the current revenue growth of Sarantis Group? | Sarantis Group revenue growth between 2023 and 2024 was 24%. |
| Is Sarantis Group profitable? | Yes, Sarantis Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
